These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19186082)

  • 21. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical demonstration of p21ras in normal and transitional cell carcinoma urothelium.
    Dunn TL; Seymour GJ; Gardiner RA; Strutton GM; Lavin MF
    J Pathol; 1988 Sep; 156(1):59-65. PubMed ID: 3057152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular determinants of outcome in bladder cancer.
    Cote RJ; Chatterjee SJ
    Cancer J Sci Am; 1999; 5(1):2-15. PubMed ID: 10188054
    [No Abstract]   [Full Text] [Related]  

  • 24. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing adenosine-to-inosine editing reactions using RNA-containing nucleoside analogs.
    Maydanovych O; Easterwood LM; Cui T; Véliz EA; Pokharel S; Beal PA
    Methods Enzymol; 2007; 424():369-86. PubMed ID: 17662850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic and bioinformatic approaches for the identification of new adenosine-to-inosine substrates.
    Sixsmith J; Reenan RA
    Methods Enzymol; 2007; 424():245-64. PubMed ID: 17662844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.
    Buick RN; Stanisic TH; Fry SE; Salmon SE; Trent JM; Krasovich P
    Cancer Res; 1979 Dec; 39(12):5051-6. PubMed ID: 498131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the gene expression of SPARC and its prognostic value for bladder cancer.
    Yamanaka M; Kanda K; Li NC; Fukumori T; Oka N; Kanayama HO; Kagawa S
    J Urol; 2001 Dec; 166(6):2495-9. PubMed ID: 11696817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.
    Levanon K; Eisenberg E; Rechavi G; Levanon EY
    EMBO Rep; 2005 Sep; 6(9):831-5. PubMed ID: 16138094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation.
    Kawahara Y; Nishikura K
    FEBS Lett; 2006 Apr; 580(9):2301-5. PubMed ID: 16574103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA editing of non-coding RNA and its role in gene regulation.
    Daniel C; Lagergren J; Öhman M
    Biochimie; 2015 Oct; 117():22-7. PubMed ID: 26051678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Alterations in Bladder Cancer.
    Porten SP
    Curr Urol Rep; 2018 Oct; 19(12):102. PubMed ID: 30357502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of adenosine-to-inosine editing of microRNAs using a conventional method.
    Kawahara Y
    Nat Protoc; 2012 Jun; 7(7):1426-37. PubMed ID: 22743833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats.
    Greenberger S; Levanon EY; Paz-Yaacov N; Barzilai A; Safran M; Osenberg S; Amariglio N; Rechavi G; Eisenberg E
    BMC Genomics; 2010 Oct; 11():608. PubMed ID: 21029430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates.
    Paz-Yaacov N; Levanon EY; Nevo E; Kinar Y; Harmelin A; Jacob-Hirsch J; Amariglio N; Eisenberg E; Rechavi G
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12174-9. PubMed ID: 20566853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visualizing adenosine-to-inosine RNA editing in single mammalian cells.
    Mellis IA; Gupte R; Raj A; Rouhanifard SH
    Nat Methods; 2017 Aug; 14(8):801-804. PubMed ID: 28604724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene regulation by SINES and inosines: biological consequences of A-to-I editing of Alu element inverted repeats.
    Chen LL; Carmichael GG
    Cell Cycle; 2008 Nov; 7(21):3294-301. PubMed ID: 18948735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-to-I RNA editing and human disease.
    Maas S; Kawahara Y; Tamburro KM; Nishikura K
    RNA Biol; 2006; 3(1):1-9. PubMed ID: 17114938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder Cancer in the Genomic Era.
    Guo CC; Czerniak B
    Arch Pathol Lab Med; 2019 Jun; 143(6):695-704. PubMed ID: 30672335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.